Citigroup
ARDS

Citigroup’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Citigroup’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-750
Closed -$2K – 6742
2021
Q4 		$2K Hold
750
– – ﹤0.01% 5742
2021
Q3 		$3K Hold
750
– – ﹤0.01% 5653
2021
Q2 		$6K Hold
750
– – ﹤0.01% 5823
2021
Q1 		$4K Hold
750
– – ﹤0.01% 5968
2020
Q4 		$5K Buy
+750
New +$5.24K ﹤0.01% 7126

Other funds holding ARDS

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Citigroup's ARDS Position: Q1 2022 in Review

Citigroup sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q1 2022, closing a stake of 750 shares — an estimated $2K sold.

Citigroup first reported a position in ARDS in Q4 2020 and held it in 5 quarters. The position peaked at $6K in Q2 2021. 22 funds tracked by Wall St. Rank hold ARDS as of Q1 2022.

  • Citigroup reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Citigroup sold 750 Aridis Pharmaceuticals Inc. Common Stock shares in Q1 2022, an estimated $2K.
  • Citigroup first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Citigroup's Aridis Pharmaceuticals Inc. Common Stock position peaked at $6K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q1 2022.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.